The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ORGANIZATION
ORGANIZATION
- JMA Exec. Mikami Wants a Hold on Info Disclosures Based on Transparency Guidelines
February 8, 2013
- Permanent Introduction of Premium for New Drug Development One of PhRMA’s “Priorities in 2013”: Japan Chair
February 5, 2013
- JMA Submits Petition Calling on MHLW to include 7 Vaccines in Public Vaccination Program
February 1, 2013
- Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers
January 31, 2013
- Number of CMRs on the Increase, Reaching 3,365: JCSOA Survey
January 30, 2013
- 1st MR Qualification Exam under New Education and Training System Attains 81.3% Pass Rate
January 29, 2013
- Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
- JMA Establishes Council to Discuss Transparency Guidelines, Will JPMA Be Able to Put Doctors’ Concerns to Rest?
January 29, 2013
- Drug Damage Watchdog Calls for Online OTC Drug Sales Ban in Principle
January 28, 2013
- JGA President Sawai Promises to Ensure Quality and Secure Stable Supply of Generics
January 24, 2013
- JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
- JPMA Approves New “Code of Practice”
January 18, 2013
- JPA Expresses Deep Regrets over Court Ruling on Online Sale of OTC Drugs
January 16, 2013
- JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
- JMA Sets Up “Council on Medical COI” Out of Concerns Over Transparency GL
January 11, 2013
- JPWA Chief Bessho Calls for Clearer Rule for Sales Tax on Ethical Drugs
January 10, 2013
- Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA
January 8, 2013
- Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi
January 7, 2013
- JPMA to Ask Abe Administration to Continue Former Dialogue with Pharmaceutical Industry: Dr Teshirogi
January 7, 2013
- NHO to Review Calculation Method for Clinical Trial Costs
December 28, 2012
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…